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Introduction
Myotubular myopathy (centronuclear 
myopathy) is a rare congenital disease 
which can manifest as a neonatal form, a 
form with an early onset, and as an adult 
form. Muscle histopathological examina-
tion is characterised by small, rounded 
muscle fibres with centrally located 
nuclei surrounded by a perinuclear halo. 
These fibres resemble fetal myotubes 
suggesting that impaired muscle matu-
ration underlies the pathology (1). How-
ever, recent findings strongly support the 
hypothesis that the X-linked myotubu-
lar myopathy (XLMTM) fibres might be 
intrinsically normal, and that an involve-
ment of the peripheral nervous system 
may explain muscular defects observed 
in the disease (2).
The severe neonatal form is X-linked 
(XLMTM) affecting mainly male infants, 
and is characterized by a severe gen-
eralized hypotonia, global muscular 
weakness and respiratory failure. Pre-
natal onset of the disease is usually indi-
cated by polyhydramnios and reduced 
fetal movements. In the absence of 
significant hypoxia neuromental neu-
ronal  development is normal. Infants 
who survive the first few months the 
cryptorchidism, long fingers and toes, 
and a head circumference above the 
90th  percentile are noted. In long term 
survivors (more than one year), com-
plications such as pyloric stenosis, 
spherocytosis, gallstones and neph-
rocalcinosis have been described (3). 
The MTM1 gene is located on Xq28 
and was identified in 1996 by positional 
cloning (4). MTM1 contains 15 exons, it 
is genomically strechted over 100 kb, 
and encodes a phosphoinositide phos-
phatase, called myotubularin, involved 
in regulating intracellular trafficking and 
vesicular transport processes (5,6).  A 
total of 192 different diseases caused by 
these mutations, have been described 
so far (7). Heterozygous female carriers 
of MTM1 gene mutations are usually 
asymptomatic, although they may dem-
onstrate abnormal muscle biopsies and 
sometimes present with a mild facial 
weakness.  Recently, rare manifesting 
carriers with mild to very severe symp-
toms due to structural abnormalities of 
one X chromosome or skewed X-inacti-
vation have been described (8,9). Auto-
somal dominant and recessive forms 
show similar histopathological findings, 
however they seem to be associated 
with a milder clinical course.
Hypoxic-ischemic encephalopathy and 
respiratory distress syndrome are fre-
quent causes of respiratory insufficien-
cy in premature infants. Clinical signs of 
neuromuscular dysfunction may also be 
present depending on the location and 
severity of the brain damage. Severe 
forms of hypoxic-ischemic encephalop-
athy (grade IV), especially those forms 
affecting the region of frontal horns of 
the lateral ventricle, are presented as 
a generalized muscular weakness with 
respiratory insufficiency, which may per-
sist for weeks (10).
Case report
A male infant was prematurely born 
at 32 week’s gestation to healthy, 
unrelated parents after a pregnancy 
complicated by polyhydramnios and 
weak fetal movements. Apgar score 
was 1/1/3 necessitating intubation and 
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ischemic encephalopathy coexist, a 
precise diagnosis is difficult to estab-
lish. Diagnosis of MTM1 has tradition-
ally relied upon finding characteristic 
pathology in muscle biopsies. How-
ever, since the detection and isolation 
of the disease-causing gene MTM1, 
much more reliable diagnosis and car-
rier detection can be offered to patients 
and their families. 
Our premature ’floppy’ infant presented 
with severe respiratory insufficiency 
immediately after birth. As the chest 
radiograph indicated a hyalomembra-
nous disease, he was artificially venti-
lated and surfactant was administered. 
At the same time the possibility of 
hypoxic-ischemic brain damage was 
taken into account (low Apgar score). 
Neurosonographic findings of periv-
entricular changes, with progressive 
ventriculomegaly and frontal cortical 
atrophy as well as brain computed tom-
ography confirmed the diagnosis of 
hypoxic-ischemic encephalopathy. The 
infant was still extremely hypotonic, 
areflexic, with minimal spontaneous 
movements of the arms and legs and 
required continuous mechanical ven-
tilation that could not be explained by 
brain damage alone. The suspected 
underlying neuromuscular disease was 
confirmed by electroneuromyogra-
phy and muscle biopsy findings and 
definitively confirmed by DNA analysis. 
The diagnosis was fairly unexpected, 
although the early death of a male infant 
in the mother’s family could have been 
an indication of a positive family history. 
However, the exact cause of death in that 
case was never established as the family 
refused molecular genetic testing.   
In conclusion, we suggest that a mus-
cle biopsy as well as molecular genetic 
analyses should be performed in ’floppy’ 
infants with respiratory distress, particu-
larly if damage of the central nervous 
system does not account for the child’s 
muscle weakness and respiratory insuf-
ficiency.  Since most male infants with 
such severe symptoms die within the first 
year, a rapid and accurate diagnosis is 
crucial, allowing the carrier testing of the 
mother, and, if required, a prenatal diag-
nosis in any subsequent pregnancy. 
artificial ventilation. The child’s fingers 
were thin and long, and the testicles 
bilaterally undescended. The moth-
er’s cousin’s son died a few days after 
birth because of the respiratory failure. 
The mother has a healthy 14-year old 
daughter from her first marriage.
The laboratory findings showed a mild 
respiratory acidosis; chest x-ray was 
typical for respiratory distress syndrome. 
Three doses of surfactant were admin-
istrated. After temporary improvement, 
respiratory insufficiency reoccurred and 
reiteration of mechanical ventilation was 
necessary. The brain ultrasonography 
showed mild ventriculomegaly.  
The child was hypotonic, with minimal 
movements of the extremities, poor ten-
don reflexes and insufficient spontane-
ous breathing.  Serum creatine kinase 
levels were within normal ranges. A 
control neurosonography showed pro-
gression of the ventriculomegaly. Com-
puted tomography of the brain revealed 
dilated ventricular cavities with frontal 
cortical brain atrophy. The electromyo-
graphic analysis showed a myopathic 
pattern. The muscle biopsy demon-
strated classical features of myotubular 
myopathy with small fibers containing 
centrally located nuclei surrounded by 
a perinuclear halo (Fig 1). The muscle 
vimentin and desmin were positive.
During the first three months several 
attempts to wean the baby from the res-
pirator had failed and the child became 
ventilator-dependent. After 13 months 
of mechanical ventilation the boy died.
Molecular genetic analyses of the 
mother’s DNA detected the frameshift 
mutation 593insA in exon 8 of the MTM1 
gene identifying her as a proven XLMTM 
carrier. In the DNA sample from her 14-
year-old daughter the 593insA mutation 
was not found excluding her from being 
an XLMTM carrier. 
Discussion
X-linked myotubular myopathy mani-
fests in boys as generalized hypotonia 
with respiratory insufficiency. In cases 
where significant perinatal hypoxia can 
be prevented, the neuromental sequels 
are minimized.
In complex cases where presence of 
myotubular myopathy and hypoxic-
Fig.1 Muscle biopsy finding: Small-sized muscle fibre with central nuclei in 
(centronuclear)  myotubular myopathy (hemalaun-eosin x 400)
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